Get our latest issue now

available for iOS, Android & web

latest issue

Latest issue


News Review
CDF shake-up / GPs and pharma’s growing divide / Dead end for off-patent drugs bill / Pharma’s transparency drive


Education, education, education
Pharma has a crucial role in providing medical education, but must be fully transparent

Rise of the machines
Artificial intelligence is the key to smarter procurement and cost savings

Medical devices under the microscope
Medical devices could soon come under increased scrutiny as the EU’s new regulation proposals enter final discussions

Power trip
Pharma companies in a dominant market position need to be sure they are not abusing their position or risk the consequences

Battle of the Pacific
What the Trans-Pacific trade deal means for pharma

Recent trends in pharma M&A / Pfizer in talks to acquire Allergan / AstraZeneca snaps up ZS Pharma / Shire buys potential competitor Dyax


Taking a breath
Pharma’s role in tackling the challenges of Chronic Obstructive Pulmonary Disease

Voyage of rediscovery
Repurposing drugs can be a quick, inexpensive solution to diseases, but pharma has to be careful when repricing older medicines


Uniphar’s Padraic Dempsey on the healthcare industry in the UK and Ireland

This month’s job moves and new appointments

49 PatientFiles

COPD patient Joan McCarthy says that pharma could do more to educate COPD patients

Business Insight

It only takes one applicant to fill a job

Click here to see the latest PharmaTimes Magazine

To subscribe go to; digital available from:

download on the app store get it on google play

Outcomes: a gamechanger for pharma

Patient-recorded outcome measures are likely to become a key part of how healthcare is provided, funded and managed. But is industry ready?

Healthcare Writer Lynne Taylor

The British government’s determination to place health outcomes at the heart of NHS decision-making presents UK-based drugmakers with a unique and potentially huge advantage over their global competitors.

Working in collaboration with the NHS to identify a product’s true value – in other words its value to the patient – has the potential to boost levels of medicines uptake and could also lead to products arriving earlier to market, both in the UK and overseas, a PharmaTimes business meeting was told recently. Leading these potentially game-changing opportunities is the NHS patient-recorded outcome measures programme, which began in 2009.

Innovative drugmakers have included PROMs in their clinical trials for many years, and the data have also long been used in observational studies and population health surveys. “We have decades of experience using these instruments and pharma is way ahead of the game. The fact they are now being measured in healthcare systems changes everything,” Professor Nancy Devlin, research director at the Office of Health Economics told the meeting. Indeed, PROMs are likely to become a key part of how all healthcare is provided, funded and managed, The King’s Fund healthcare policy think-tank has forecast.

So what exactly are PROMs and why should this matter to pharma? You can find out by reading the full article online here

See what's coming up in the March issue [PDF]

Visions 2014 supplement


Creating a balance between
 reimbursement and innovation

Real-world data
How to plan early

NHS reform
What more does pharma need to do?

We asked you what the big developments in 2014 will be?

Change is key to opportunity
What to adapt for

Salesforce effectiveness
Future-proofing the sales team

Myeloma research
An example of a new R&D model

Visions in a nutshell

The complete Visions 2014 supplement PDF is available to download


Subscription is free to qualifying UK subscribers

To read articles in full and features in the magazine, why not subscribe

Reprints available.

PharmaTimes Magazine print and digital versions have a total circulation of 23,184, including 8,000 NHS healthcare professionals: chief pharmacists, medicines management and primary care commissioners.

Follow us: @PharmaTimes on Twitter

Find a job

Website Search

Search News Search Magazine

Business Insight


Competitions News


International Clinical Researcher of the Year 2016

Last chance to enter!

Elert Signup!